{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:20:02Z","timestamp":1761920402673,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University of Turku Doctoral Program of Clinical Investigation"},{"name":"Finnish MS Foundation"},{"DOI":"10.13039\/501100007083","name":"Orion Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007459","name":"Multiple Sclerosis International Federation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007459","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.msard.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T06:53:20Z","timestamp":1518159200000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Humoral response to John Cunningham virus during pregnancy in multiple sclerosis"],"prefix":"10.1016","volume":"21","author":[{"given":"M.","family":"Saraste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Atula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hurme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-M.","family":"Surcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.","family":"Maghzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Airas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2018.02.008_bib1","first-page":"668","article-title":"Immunological markers for PML prediction in MS patients treated with Natalizumab","volume":"5","author":"Antoniol","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2018.02.008_bib2","article-title":"Correlation between anti-JC-virus and anti-cytomegalovirus, -Epstein-Barr-virus and -measles\/-rubella\/-varicella-zoster-virus antibodies","author":"Auer","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.msard.2018.02.008_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13365-013-0222-6","article-title":"Immune surveillance and response to JC virus infection and PML","volume":"20","author":"Beltrami","year":"2014","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.msard.2018.02.008_bib4","first-page":"669","article-title":"Plasma volume expansion in early pregnancy","volume":"97","author":"Bernstein","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.msard.2018.02.008_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ene.12304","article-title":"Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial","volume":"21","author":"Bozic","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2018.02.008_bib6","article-title":"JCV serology in time: 3 years of follow-up","author":"Cambron","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2018.02.008_bib7","first-page":"289","article-title":"Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation","volume":"53","author":"Coleman","year":"1983","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2018.02.008_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2018.02.008_bib9","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/ane.12222","article-title":"Normal outcome of pregnancy with ongoing treatment with natalizumab","volume":"129","author":"Fagius","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2018.02.008_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","article-title":"Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI","volume":"73","author":"Farrell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.02.008_bib11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamaneurol.2014.209","article-title":"Natalizumab use during the third trimester of pregnancy","volume":"71","author":"Haghikia","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2018.02.008_bib12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/1352458510372629","article-title":"Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland","volume":"16","author":"Jalkanen","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.02.008_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.24574","article-title":"Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant","volume":"79","author":"Jelcic","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2018.02.008_bib14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/infdis\/jiv138","article-title":"Pregnancy does not attenuate the antibody or plasmablast response to inactivated influenza vaccine","volume":"212","author":"Kay","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.msard.2018.02.008_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/ane.12475","article-title":"Anti-JC virus seroprevalence in a Finnish MS cohort","volume":"133","author":"Kolasa","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2018.02.008_bib16","first-page":"1077","article-title":"Pregnancy and infection","volume":"371","author":"Kourtis","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2018.02.008_bib17","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1080\/00016340802428146","article-title":"Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy","volume":"87","author":"Larsson","year":"2008","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.msard.2018.02.008_bib18","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/S0264-410X(03)00331-1","article-title":"How immune mechanisms are affected by pregnancy","volume":"21","author":"Luppi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2018.02.008_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003604","article-title":"Rescue of severe brain and cervical cord IRIS by restarting natalizumab in a pregnant MS patient","author":"Massey","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.02.008_bib20","doi-asserted-by":"crossref","first-page":"851712","DOI":"10.1155\/2013\/851712","article-title":"Listeriosis during pregnancy: a public health concern","volume":"2013","author":"Mateus","year":"2013","journal-title":"ISRN Obstet. Gynecol."},{"key":"10.1016\/j.msard.2018.02.008_bib21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jmv.23320","article-title":"Dynamics of pregnancy-associated polyomavirus urinary excretion: a prospective longitudinal study","volume":"84","author":"McClure","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.msard.2018.02.008_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fimmu.2015.00159","article-title":"Immune system involvement in the pathogenesis of JC virus induced PML: what is learned from studies of patients with underlying diseases and therapies as risk factors","volume":"6","author":"Monaco","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2018.02.008_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: a unique complexity","volume":"63","author":"Mor","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.msard.2018.02.008_bib24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/1352458513477925","article-title":"Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort","volume":"19","author":"Olsson","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.02.008_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Plavina","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2018.02.008_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/aji.12289","article-title":"Understanding the complexity of the immune system during pregnancy","volume":"72","author":"Racicot","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"journal-title":"Mult. Scler.","year":"2017","author":"Schwab","key":"10.1016\/j.msard.2018.02.008_bib27"},{"key":"10.1016\/j.msard.2018.02.008_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/aji.12355","article-title":"Viral infections during pregnancy","volume":"73","author":"Silasi","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.msard.2018.02.008_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.msard.2018.02.008_bib30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","article-title":"Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort","volume":"78","author":"Trampe","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.02.008_bib31","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1177\/1352458514567728","article-title":"Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy","volume":"21","author":"Vennegoor","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.02.008_bib32","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ene.12988","article-title":"High cumulative JC virus seroconversion rate during long-term use of natalizumab","volume":"23","author":"Vennegoor","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2018.02.008_bib33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/1352458514554056","article-title":"Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis","volume":"21","author":"Vukusic","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.02.008_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0163-4453(92)92928-C","article-title":"Reactivation of tuberculous lymphadenitis during pregnancy","volume":"24","author":"Warner","year":"1992","journal-title":"J. Infect."},{"key":"10.1016\/j.msard.2018.02.008_bib35","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00129.2016","article-title":"The enigma of continual plasma volume expansion in pregnancy; critical role of the renin\/angiotensin\/aldosterone system","author":"West","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481830052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481830052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:40:46Z","timestamp":1761900046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103481830052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"alternative-id":["S221103481830052X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.02.008","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral response to John Cunningham virus during pregnancy in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}